| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
19,737 |
10,675 |
$1.42M |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
7,964 |
5,937 |
$954K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,983 |
7,199 |
$699K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
12,506 |
7,407 |
$589K |
| 95923 |
|
2,404 |
1,727 |
$157K |
| 95913 |
|
933 |
645 |
$135K |
| 95921 |
|
2,401 |
1,724 |
$94K |
| 93922 |
|
1,217 |
921 |
$81K |
| 76800 |
|
989 |
703 |
$64K |
| 95886 |
|
1,722 |
649 |
$61K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
528 |
384 |
$58K |
| 76881 |
|
998 |
703 |
$51K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,528 |
996 |
$46K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
463 |
382 |
$42K |
| 92270 |
|
888 |
336 |
$41K |
| 76942 |
|
1,015 |
707 |
$40K |
| 95887 |
|
926 |
644 |
$34K |
| 92546 |
|
751 |
332 |
$32K |
| 95926 |
|
435 |
327 |
$30K |
| 92540 |
|
449 |
331 |
$25K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
2,236 |
913 |
$23K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,787 |
773 |
$22K |
| 96132 |
|
425 |
325 |
$22K |
| 95925 |
|
289 |
225 |
$21K |
| 96127 |
|
2,824 |
2,144 |
$21K |
| 72275 |
|
252 |
190 |
$19K |
| 96116 |
|
479 |
355 |
$17K |
| 64483 |
|
69 |
57 |
$15K |
| 99406 |
|
1,026 |
638 |
$14K |
| 92548 |
|
445 |
332 |
$14K |
| 64493 |
|
105 |
71 |
$14K |
| 92537 |
|
449 |
331 |
$10K |
| 99070 |
|
801 |
567 |
$9K |
| 97124 |
|
728 |
381 |
$9K |
| 64494 |
|
121 |
84 |
$8K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
123 |
85 |
$8K |
| 64495 |
|
102 |
69 |
$7K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
2,227 |
1,409 |
$7K |
| 96138 |
|
425 |
325 |
$7K |
| 64484 |
|
84 |
44 |
$7K |
| 97750 |
|
435 |
326 |
$6K |
| 97012 |
|
938 |
444 |
$6K |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
599 |
424 |
$5K |
| 99215 |
Prolong outpt/office vis |
68 |
55 |
$5K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
594 |
439 |
$4K |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
2,768 |
1,581 |
$4K |
| 97010 |
|
1,867 |
807 |
$4K |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
840 |
572 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,093 |
2,018 |
$4K |
| 20553 |
|
155 |
114 |
$3K |
| G8482 |
Influenza immunization administered or previously received |
477 |
326 |
$3K |
| 99443 |
|
125 |
76 |
$2K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
357 |
265 |
$2K |
| G8730 |
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented |
1,908 |
1,059 |
$2K |
| 97026 |
|
219 |
118 |
$2K |
| 92547 |
|
450 |
331 |
$1K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
168 |
98 |
$1K |
| 97164 |
|
92 |
64 |
$1K |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
135 |
89 |
$1K |
| 86328 |
|
40 |
33 |
$950.51 |
| 77003 |
|
16 |
13 |
$707.04 |
| 97537 |
|
76 |
25 |
$703.90 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
130 |
53 |
$659.98 |
| 1006F |
|
793 |
455 |
$549.67 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
68 |
54 |
$441.50 |
| 97014 |
|
84 |
54 |
$413.16 |
| 97535 |
Self-care/home management training, each 15 minutes |
68 |
26 |
$406.53 |
| 99484 |
|
40 |
26 |
$311.52 |
| 97116 |
|
17 |
16 |
$309.12 |
| 81001 |
|
86 |
75 |
$230.93 |
| G8483 |
Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) |
36 |
28 |
$194.58 |
| 4004F |
|
580 |
347 |
$62.50 |
| 3700F |
|
1,370 |
1,083 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
296 |
188 |
$0.00 |
| 1036F |
|
131 |
101 |
$0.00 |
| 1101F |
|
53 |
26 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
365 |
240 |
$0.00 |
| Q4206 |
Fluid flow or fluid gf, 1 cc |
58 |
37 |
$0.00 |
| G9908 |
Patient identified as tobacco user did not receive tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
45 |
35 |
$0.00 |
| G8952 |
Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given |
14 |
12 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
34 |
29 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
147 |
118 |
$0.00 |
| G8511 |
Screening for depression documented as positive, follow-up plan not documented, reason not given |
26 |
24 |
$0.00 |
| 96103 |
|
24 |
21 |
$0.00 |
| G9500 |
Radiation exposure indices documented in final report for procedure using fluoroscopy |
14 |
12 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
33 |
28 |
$0.00 |